Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice

Non-medical androgen use is a growing global issue among recreational gym-goers. The intersection of severe health risks and substance dependence highlights the urgent need for an integrated, medical and harm-reduction approach-ideally delivered in specialized primary care settings. Early detection of cardiovascular risk factors is crucial for mitigating the often-overlooked yet potentially reversible complications. A reassessment of legal and clinical measures is warranted to optimize harm reduction and provision of care. Despite best practices and a year of abstinence from non-medical androgen use, the patient's fatal outcome underscores the critical need for further research, heightened awareness, and more robust prevention and harm reduction strategies for those affected by non-medical androgen use.

Authors

Institutions

Publication Details

Journal
Harm Reduction Journal
Published
2025-08-21
DOI
https://doi.org/10.1186/s12954-025-01294-w
Citations
3
Primary Topic
Hormonal and reproductive studies
Type
article
Field-Weighted Citation Impact
3.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice

Oliver Senn, H.‐W. Hammer, Philip Bruggmann, Raphael Magnolini et al.
3 citations
Harm Reduction Journal
Hormonal and reproductive studies
3.88
article

Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice

Oliver Senn, H.‐W. Hammer, Philip Bruggmann, Raphael Magnolini, S. Bottoni, Joël Capraro
article en
3 citations

Abstract

Non-medical androgen use is a growing global issue among recreational gym-goers. The intersection of severe health risks and substance dependence highlights the urgent need for an integrated, medical and harm-reduction approach-ideally delivered in specialized primary care settings. Early detection of cardiovascular risk factors is crucial for mitigating the often-overlooked yet potentially reversible complications. A reassessment of legal and clinical measures is warranted to optimize harm reduction and provision of care. Despite best practices and a year of abstinence from non-medical androgen use, the patient's fatal outcome underscores the critical need for further research, heightened awareness, and more robust prevention and harm reduction strategies for those affected by non-medical androgen use.

Harm Reduction JournalVol. 22(1)
University of Zurich (CH), Herzgefäss Medizin Klinik Im Park (CH), Kantonsschule Stadelhofen (CH), Addiction Switzerland (CH), University Hospital of Zurich (CH), GastroZentrum Hirslanden Zürich (CH), Kantonsspital Aarau (CH)
Openalex Percentile: Top 6%
Hormonal and reproductive studies
3.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.